News and Informations

Biofourmis Collaborates with Brigham and Women’s Hospital to Improve Patient Home Care

Biofourmis, a Singapore-based health analytics platform, has entered into a collaboration with Brigham and Women’s Hospital in Boston, US to co-develop improvements to their proprietary analytics engine, Biovitals™ for Brigham’s Home Hospital Programme.

Read More

Mundipharma and Biofourmis join forces to Revolutionise Pain Measurement and Management!

Leveraging on our biovitals™ analytics engine, painfocus™ uses advanced machine learning that combines multiple physiology biomarkers captured using wearable devices to calculate the presence and severity of pain, enabling clinicians to personalize treatment and manage their patients.

Read More

Making use of A.I. in health care

Kuldeep Singh Rajput, CEO of Biofourmis Group, explains how the start-up’s health platform looks at changes in a patient’s physiological data.

Read More

NSI Ventures Announces First Close of NSI Ventures II, L.P., Investment in Biofourmis and New Team Members

NSI is also pleased to announce that NSI Ventures II, L.P. has made its first investment in Biofourmis — a Singapore-based healthcare technology company using proprietary AI technology to prevent avoidable readmissions for post-acute cardiac patients. Aviva, a leading global insurance company also invested in Biofourmis this round.

Read More

NSI Ventures hits first close on new $125M fund for Southeast Asia

On that note, it announced a first investment from the new vehicle: leading a $5 million Series A fundraise for Biofourmis, a Singapore-based company that has developed a health analytics platform. Aviva co-led the round via its investment arm while Biofourmis announced a partnership with Mayo Clinic.

Read More

Mayo Clinic deal and $5m funding for health data platform Biofourmis

Singapore-based health analytics platform Biofourmis announced the close of its series A funding round today, while also unveiling a partnership with US medical research institute, the Mayo Clinic.

Read More

Biofourmis raises US$5m in Series A funding from NSI Ventures, Aviva Ventures

Biofourmis has raised US$5 million in a Series A round of funding from venture capital firm NSI Ventures and Aviva Ventures, the corporate venture arm of insurer Aviva.

Read More

Biofourmis raises US$5m in Series A funding from NSI Ventures, Aviva Ventures

Biofourmis has raised US$5 million in a Series A round of funding from venture capital firm NSI Ventures and Aviva Ventures, the corporate venture arm of insurer Aviva.

Read More

MAS loosens rules for finance companies to help SMEs raise funds

Finance companies and enterprises welcome raising of regulatory lending caps

Read More

This Singaporean startup wants to save you by predicting medical crises before they arise

This Singaporean startup wants to save you by predicting medical crises before they arise

Read More

Biofourmis raises US$1 million angel funding

Singapore: Biofourmis raises US$1 million angel funding

Read More

Singapore’s Biofourmis raises $1m to bring computing power, AI to manage health-tech data

Singapore’s Biofourmis raises $1m to bring computing power, AI to manage health-tech data

Read More

Whether you are a healthcare provider
or a payer or a pharmaceutical,
biofourmis empowers you

Get In Touch